# Tenaya Therapeutics, Inc.: Form 8-K, filed Jul 2, 2026

- Company: [Tenaya Therapeutics, Inc.](/companies/tnya.md) (CIK 1858848)
- Form: 8-K
- Filed: 2026-07-02
- Accepted by EDGAR: Jul 2, 2026, 17:00 ET
- Period: 2026-06-29
- Accession: 0001193125-26-294879
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1858848/000119312526294879/tnya-20260629.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1858848/000119312526294879/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1858848/000119312526294879/tnya-20260629.htm

Filed Jul 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-294879. Last ingested by Listed: Nov 4, 2026, 17:31 ET. No prices; not investment advice.